Oncothermia

Complex therapy by em and fractal physiology

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Abstract

Hyperthermia was the very first oncotherapy in human medicine. Despite its long history it has not achieved any breakthrough in clinical practices. The discovery of electromagnetism gave new hopes a century ago, however some controversies blocked its wide application. Oncothermia is a renewal, applying the synergy of the bioelectromagnetism with fractal physiology. Its basic approach makes selective energy absorption targeting the membrane rafts of the malignant cells. In this meaning this is a nanotechnology, treating the naturally present nano-particles (rafts) in 5 nm-range. The goal of the treatment is to induce apoptosis and drive the lost complex structure by possible re-synchronization of the autonomic malignant cells. The treatment tries avoid the constrains which induce unhelpful physiological reactions like the increase of the blood-flow which supports the tumor by nutrients and promotes metastatic processes. Oncothermia re-establishes the lost complexity of the malignant processes.

Original languageEnglish
Title of host publication2014 31th URSI General Assembly and Scientific Symposium, URSI GASS 2014
PublisherInstitute of Electrical and Electronics Engineers Inc.
ISBN (Print)9781467352253
DOIs
Publication statusPublished - Oct 17 2014
Event31st General Assembly and Scientific Symposium of the International Union of Radio Science, URSI GASS 2014 - Beijing, China
Duration: Aug 16 2014Aug 23 2014

Other

Other31st General Assembly and Scientific Symposium of the International Union of Radio Science, URSI GASS 2014
CountryChina
CityBeijing
Period8/16/148/23/14

Fingerprint

Electromagnetism
Physiology
Energy absorption
Cell death
Nanotechnology
Fractals
Nutrients
Medicine
Tumors
Synchronization
Blood
Membranes

ASJC Scopus subject areas

  • Electrical and Electronic Engineering
  • Computer Networks and Communications

Cite this

Szász, A. (2014). Oncothermia: Complex therapy by em and fractal physiology. In 2014 31th URSI General Assembly and Scientific Symposium, URSI GASS 2014 [6930100] Institute of Electrical and Electronics Engineers Inc.. https://doi.org/10.1109/URSIGASS.2014.6930100

Oncothermia : Complex therapy by em and fractal physiology. / Szász, A.

2014 31th URSI General Assembly and Scientific Symposium, URSI GASS 2014. Institute of Electrical and Electronics Engineers Inc., 2014. 6930100.

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Szász, A 2014, Oncothermia: Complex therapy by em and fractal physiology. in 2014 31th URSI General Assembly and Scientific Symposium, URSI GASS 2014., 6930100, Institute of Electrical and Electronics Engineers Inc., 31st General Assembly and Scientific Symposium of the International Union of Radio Science, URSI GASS 2014, Beijing, China, 8/16/14. https://doi.org/10.1109/URSIGASS.2014.6930100
Szász A. Oncothermia: Complex therapy by em and fractal physiology. In 2014 31th URSI General Assembly and Scientific Symposium, URSI GASS 2014. Institute of Electrical and Electronics Engineers Inc. 2014. 6930100 https://doi.org/10.1109/URSIGASS.2014.6930100
Szász, A. / Oncothermia : Complex therapy by em and fractal physiology. 2014 31th URSI General Assembly and Scientific Symposium, URSI GASS 2014. Institute of Electrical and Electronics Engineers Inc., 2014.
@inproceedings{affa476c34a543c9b20de533546b48bf,
title = "Oncothermia: Complex therapy by em and fractal physiology",
abstract = "Hyperthermia was the very first oncotherapy in human medicine. Despite its long history it has not achieved any breakthrough in clinical practices. The discovery of electromagnetism gave new hopes a century ago, however some controversies blocked its wide application. Oncothermia is a renewal, applying the synergy of the bioelectromagnetism with fractal physiology. Its basic approach makes selective energy absorption targeting the membrane rafts of the malignant cells. In this meaning this is a nanotechnology, treating the naturally present nano-particles (rafts) in 5 nm-range. The goal of the treatment is to induce apoptosis and drive the lost complex structure by possible re-synchronization of the autonomic malignant cells. The treatment tries avoid the constrains which induce unhelpful physiological reactions like the increase of the blood-flow which supports the tumor by nutrients and promotes metastatic processes. Oncothermia re-establishes the lost complexity of the malignant processes.",
author = "A. Sz{\'a}sz",
year = "2014",
month = "10",
day = "17",
doi = "10.1109/URSIGASS.2014.6930100",
language = "English",
isbn = "9781467352253",
booktitle = "2014 31th URSI General Assembly and Scientific Symposium, URSI GASS 2014",
publisher = "Institute of Electrical and Electronics Engineers Inc.",

}

TY - GEN

T1 - Oncothermia

T2 - Complex therapy by em and fractal physiology

AU - Szász, A.

PY - 2014/10/17

Y1 - 2014/10/17

N2 - Hyperthermia was the very first oncotherapy in human medicine. Despite its long history it has not achieved any breakthrough in clinical practices. The discovery of electromagnetism gave new hopes a century ago, however some controversies blocked its wide application. Oncothermia is a renewal, applying the synergy of the bioelectromagnetism with fractal physiology. Its basic approach makes selective energy absorption targeting the membrane rafts of the malignant cells. In this meaning this is a nanotechnology, treating the naturally present nano-particles (rafts) in 5 nm-range. The goal of the treatment is to induce apoptosis and drive the lost complex structure by possible re-synchronization of the autonomic malignant cells. The treatment tries avoid the constrains which induce unhelpful physiological reactions like the increase of the blood-flow which supports the tumor by nutrients and promotes metastatic processes. Oncothermia re-establishes the lost complexity of the malignant processes.

AB - Hyperthermia was the very first oncotherapy in human medicine. Despite its long history it has not achieved any breakthrough in clinical practices. The discovery of electromagnetism gave new hopes a century ago, however some controversies blocked its wide application. Oncothermia is a renewal, applying the synergy of the bioelectromagnetism with fractal physiology. Its basic approach makes selective energy absorption targeting the membrane rafts of the malignant cells. In this meaning this is a nanotechnology, treating the naturally present nano-particles (rafts) in 5 nm-range. The goal of the treatment is to induce apoptosis and drive the lost complex structure by possible re-synchronization of the autonomic malignant cells. The treatment tries avoid the constrains which induce unhelpful physiological reactions like the increase of the blood-flow which supports the tumor by nutrients and promotes metastatic processes. Oncothermia re-establishes the lost complexity of the malignant processes.

UR - http://www.scopus.com/inward/record.url?scp=84919779421&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84919779421&partnerID=8YFLogxK

U2 - 10.1109/URSIGASS.2014.6930100

DO - 10.1109/URSIGASS.2014.6930100

M3 - Conference contribution

SN - 9781467352253

BT - 2014 31th URSI General Assembly and Scientific Symposium, URSI GASS 2014

PB - Institute of Electrical and Electronics Engineers Inc.

ER -